Skip to main content

Table 3 Sensory nerve conduction measurements

From: Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial

 

Group

Pre-chemotherapy

Post-chemotherapy*

p-value #

Sural nerve

    

a-SAP(μV)

Omega 3

13.27 (5.02)

13.33 (5.91)

.015

 

Placebo

13.70 (7.46)

9.74 (5.96)

 

SCV(m/s)

Omega 3

54.35 (7.13)

54.79 (8.35)

.514

 

Placebo

53.50 (6.79)

52.52 (8.05)

 

Ulnar nerve

    

a-SAP(μV)

Omega 3

34.23 (14.85)

24.53 (13.95)

.454

 

Placebo

31.15 (14.02)

21.53 (13.70)

 

SCV(m/s)

Omega 3

57.30 (5.18)

55.82 (6.35)

.212

 

Placebo

55.80 (4.90)

53.19 (7.29)

 
  1. a-SAP, sensory action potential amplitude; SCV, sensory conduction velocity.
  2. * One month after the cessation of chemotherapy.
  3. # p value is reported based on the analysis of covariance.